menu search

After a rocky 2021, uber may be a top pick in the new year, analysts say

Despite losing some investor confidence amid continued Covid headwinds, Uber could be positioning itself for a comeback in 2022, analysts say....

January 8, 2022, 2:20 pm

After a rocky 2021, uber may be a top pick in the new year, analysts say

Despite losing some investor confidence amid continued Covid headwinds, Uber could be positioning itself for a comeback in 2022, analysts say....

January 8, 2022, 2:20 pm

The 3 smartest tech stocks to buy in 2022 and beyond

Meta, Veeva, and CrowdStrike will easily weather the near-term macro headwinds....

January 5, 2022, 7:57 pm

The 3 smartest tech stocks to buy in 2022 and beyond

Meta, Veeva, and CrowdStrike will easily weather the near-term macro headwinds....

January 5, 2022, 7:57 pm

The 3 smartest tech stocks to buy in 2022 and beyond

Meta, Veeva, and CrowdStrike will easily weather the near-term macro headwinds....

January 5, 2022, 7:57 pm

Acelrx: battered and bruised but ready for recovery in 2022

AcelRx continues to be an abysmal investment as the company's flagship product DSUVIA has struggled to gain traction in the middle of COVID-19 headwin...

January 4, 2022, 10:56 pm

Acelrx: battered and bruised but ready for recovery in 2022

AcelRx continues to be an abysmal investment as the company's flagship product DSUVIA has struggled to gain traction in the middle of COVID-19 headwin...

January 4, 2022, 10:56 pm

Acelrx: battered and bruised but ready for recovery in 2022

AcelRx continues to be an abysmal investment as the company's flagship product DSUVIA has struggled to gain traction in the middle of COVID-19 headwin...

January 4, 2022, 10:56 pm

Caredx: short-term headwinds will pass, longer-term high growth investment case remains

Although CareDx (CDNA) recently received inquiries from the DOJ and SEC, the longer-term investment case remains intact. CDNA has only begun to scratc...

January 4, 2022, 10:49 pm

Caredx: short-term headwinds will pass, longer-term high growth investment case remains

Although CareDx (CDNA) recently received inquiries from the DOJ and SEC, the longer-term investment case remains intact. CDNA has only begun to scratc...

January 4, 2022, 10:49 pm

Caredx: short-term headwinds will pass, longer-term high growth investment case remains

Although CareDx (CDNA) recently received inquiries from the DOJ and SEC, the longer-term investment case remains intact. CDNA has only begun to scratc...

January 4, 2022, 10:49 pm

Top 10 growth investing stocks for 2022

We believe that growth investing is a long-term endeavor. Short-term headwinds such as inflation and th...

January 2, 2022, 8:27 am

Top 10 growth investing stocks for 2022

We believe that growth investing is a long-term endeavor. Short-term headwinds such as inflation and th...

January 2, 2022, 8:27 am

Top 10 growth investing stocks for 2022

We believe that growth investing is a long-term endeavor. Short-term headwinds such as inflation and th...

January 2, 2022, 8:27 am

Clovis oncology is now discounted and offers a great risk-reward

Clovis Oncology has had a rough 2021, with Rubraca sales continuing to disappoint. The company's Q3 sales revealed a slight increase quarter-over-quar...

December 30, 2021, 1:17 pm

Clovis oncology is now discounted and offers a great risk-reward

Clovis Oncology has had a rough 2021, with Rubraca sales continuing to disappoint. The company's Q3 sales revealed a slight increase quarter-over-quar...

December 30, 2021, 1:17 pm

Clovis oncology is now discounted and offers a great risk-reward

Clovis Oncology has had a rough 2021, with Rubraca sales continuing to disappoint. The company's Q3 sales revealed a slight increase quarter-over-quar...

December 30, 2021, 1:17 pm

Stryve foods: strong growth expected in 2022

2021 has been a highly productive year for Stryve despite severe inflation and other macroeconomic headwinds. Stryve has a substantial pipeline of new...

December 29, 2021, 9:38 pm

Stryve foods: strong growth expected in 2022

2021 has been a highly productive year for Stryve despite severe inflation and other macroeconomic headwinds. Stryve has a substantial pipeline of new...

December 29, 2021, 9:38 pm

Stryve foods: strong growth expected in 2022

2021 has been a highly productive year for Stryve despite severe inflation and other macroeconomic headwinds. Stryve has a substantial pipeline of new...

December 29, 2021, 9:38 pm


Search within

Pages Search Results: